
Article 1 
Annexes I, II, III and IV of Regulation (EEC) No 2377/90 are hereby amended as set out in the Annex hereto.
Article 2 
This Regulation shall enter into force on the sixtieth day following its publication in the Official Journal of the European Communities.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 8 January 1997.
For the Commission
Martin BANGEMANN
Member of the Commission
ANNEX

Regulation (EEC) No 2377/90 is modified as follows:

A.. Annex I is modified as follows:

2.. Anti-parasitic agents

2.3. Agents acting against endo- and ectoparasites

2.3.1. Avermectins

Pharmacologically active substance Marker residue Animal Species MRLs Target tissues Other provisions

‘2.3.1.4. Eprinomectin
 Eprinomectin B1a Bovine 30 μg/kg Muscle 
30 μg/kg Fat
600 μg/kg Liver
100 μg/kg Kidney
30 μg/kg Milk’
B.. Annex II is modified as follows:

1.. Inorganic chemicals

Pharmacologically active substance(s) Animal Species Other provisions

‘1.24. Zinc acetate
 All food producing species 

1.25. Zinc chloride
 All food producing species 

1.26. Zinc gluconate
 All food producing species 

1.27. Zinc oleate
 All food producing species 

1.28. Zinc stearate
 All food producing species’ 
2.. Organic compounds

Pharmacologically active substance(s) Animal Species Other provisions

‘2.69. Chlorhexidine
 All food producing species For topical use only

2.70. Glycerol formal
 All food producing species 

2.71. Hesperidin
 Equidae 

2.72. Hesperidin methyl chalcone
 Equidae 

2.73. Menbutone
 Bovine, ovine, caprine, porcine, equidae 

2.74. Quatresin
 All food producing species For use as preservative only at concentrations of up to 0,5 %’
C.. Annex III is modified as follows:

1.. Anti-infectious agents

1.2. Antibiotics

1.2.6. Quinolones

Pharmacologically active substance Marker residue Animal Species MRLs Target tissues Other provisions

‘1.2.6.4. Flumequine
 Flumequine Bovine, ovine, porcine, chicken 50 μg/kg Muscle, fat or fat/skin Provisional MRLs expire on 1.1.2000’
100 μg/kg Liver
300 μg/kg Kidney
Salmonidae 150 μg/kg Muscle/skin

1.2.8. Tetracyclines

Pharmacologically active substance Marker residue Animal Species MRLs Target tissues Other provisions

‘1.2.8.1. Doxycycline
 Sum of parent drug and its 4-epimer Porcine, poultry 600 μg/kg Kidney Provisional MRLs expire on 1.1.1998’
300 μg/kg Liver, skin/fat
100 μg/kg Muscle
Bovine 600 μg/kg Kidney
300 μg/kg Liver
100 μg/kg Muscle
2.. Antiparasitic agents

2.1. Agents acting against endoparasites

2.1.1. Benzimidazoles and pro-benzimidazoles

Pharmacologically active substance Marker residue Animal Species MRLs Target tissues Other provisions

‘2.1.1.10. Albendazole sulphoxide
 Sum of albendazole, albendazole sulphoxide, albendazole sulphone, and albendazole 2-amino sulphone, expressed as albendazole Bovine, ovine, pheasant 1 000 μg/kg Liver Provisional MRLs expire on 1.1.1998’
500 μg/kg Kidney
100 μg/kg Muscle, fat
Bovine, ovine 100 μg/kg Milk
D.. Annex IV is modified as follows:
List of pharmacologically active substances for which no maximum levels can be fixed:
'
8. Chlorpromazine
'
